Brello Health review: count the weeks between renewal charges

Brello Health advertises compounded semaglutide and tirzepatide in multi-month packages. The advertised monthly averages can obscure the payment calendar: its three-month offers renew every eleven weeks, and its six-month tirzepatide offer renews every twenty-two weeks. Comparing the actual charge dates is more useful than multiplying an advertised monthly average by twelve.

We checked the public offers, FAQs, refund policy and terms on October 15, 2026. This is a source-based review, not an order, patient experience or independent clinical-quality assessment. We did not complete medical intake or checkout, verify an individual prescription or assign a numerical rating.

What the package pages actually charge

The semaglutide offer advertises $133 per month but specifies $399 charged today and $399 every eleven weeks. The three-month tirzepatide offer specifies $499 today and $499 every eleven weeks, advertised as $166 per month. Dividing $499 by three gives about $166.33, so the headline is rounded, not a separate $166 recurring bill.

The six-month tirzepatide page specifies $894 today and $894 every twenty-two weeks, with a $149 monthly average. Eleven weeks is 77 days and twenty-two weeks is 154 days. Neither is the same interval as three or six calendar months. Budget from the stated renewal schedule and confirm the exact quantity and duration of the prescribed supply.

The reviewed pages describe three- or six-month minimums, depending on the plan, alongside “cancel anytime” language. Cancellation does not turn the initial package into a sequence of independently refundable monthly purchases. The homepage’s broader plans-from-$79 message is not the price of either reviewed GLP-1 package.

The offers include medication if prescribed, a provider health review, supplies and shipping. They also describe app access and support. Confirm any laboratory, outside-care or other product costs separately. The full package price is a cash offer; this review does not establish insurance coverage or financing approval.

Payment comes before intake on the product pages

The product pages say checkout is followed by the online health intake, with a government-issued ID required. They promise a full refund if the provider does not approve treatment. The general FAQ says applicants are charged the package amount “if approved,” so ask whether the initial transaction is an authorization or a captured charge and how denial refunds are handled.

The refund policy provides a full refund before the health review is performed, or when the clinician finds the person unsuitable and no prescription has been issued. After a prescription is issued but before medication is dispensed, it describes a refund minus a $50 professional-service fee if the request arrives within the specified twenty-four-hour window.

The twenty-four-hour window is narrow

The refund policy counts the window from the timestamp of the notification that review is complete and a prescription has been issued. The FAQ instead describes twenty-four hours from completion of the provider review. If those times differ, the public wording leaves a practical uncertainty; request clarification and do not wait for a shipment notice.

Once medication has been dispensed, the policy says it is nonrefundable. This cutoff can occur before delivery. The reviewed general offer pages say a subscription can be canceled anytime but do not establish a precise advance-notice period for every renewal. Confirm the next processing date and cancellation method in the selected agreement before payment.

The product pages also advertise conditional transfer protection if the clinician does not continue an existing patient at or near the current strength. They require recent use, proof of the current prescription before review, completed intake and no previous refund under that policy. This is not a guarantee of a particular prescription or a reason to choose a dose. Ask how that exception interacts with the ordinary refund cutoff.

Shipping problems have their own process

The refund policy asks patients to report a medication or dispensing concern to the pharmacy immediately, with a forty-eight-hour delivery reporting window for eligibility under its replacement/refund process. Keep the medication and packaging for investigation; the window is a commercial policy, not a reason to delay a medical concern.

For a package marked delivered but not received, the detailed policy allows an investigation and says a replacement payment may be refunded if non-receipt is confirmed. Its FAQ instead describes no reshipment after delivery confirmation and paying for a new order. Those statements differ, so obtain the current process in writing. The policy also places responsibility on the customer for carrier changes requested after shipping, subject to applicable law.

The platform and pharmacy have different responsibilities

The terms identify Brello, LLC as the platform and name AP Max, Inc. doing business as Southend Pharmacy as a prescription-fulfillment provider. Independent clinicians make medical decisions. A named partner does not verify the exact clinician, pharmacy assignment, formulation or state availability for an individual order.

The FAQ’s three-to-five-business-day estimate concerns shipping after approval in states marked available without delays. It is not a measured support-response time or a guaranteed delivery date. Check the service’s current state availability and the pharmacy information on the prescription before relying on a general website claim.

These reviewed packages are compounded preparations. FDA notes that such drugs are not FDA-approved or reviewed before marketing for safety, effectiveness or quality. Our dual-action guide explains why receptor language is not proof of product equivalence. The Trava review offers another comparison in which the price changes with the prescription rather than being presented as a flat package headline.